Jenkem Technology Co., Ltd. (SHA:688356)

Market Cap	4.12B +9.9%
Revenue (ttm)	328.26M +41.9%
Net Income	72.23M +164.9%
EPS	1.19 +164.5%
Shares Out	60.50M
PE Ratio	57.33
Forward PE	n/a
Dividend	0.31 (0.45%)
Ex-Dividend Date	Jul 11, 2025

Volume	492,739
Open	68.62
Previous Close	68.62
Day's Range	66.91 - 68.62
52-Week Range	65.70 - 118.68
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Jenkem Technology

Jenkem Technology Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medical and pharmaceutical polyethylene glycol derivative (PEG) products in China and internationally. The company offers high molecular weight polyethylene glycol derivatives comprising branched, methoxylated, bifunctionalized, heterofunctionalized disubstituted, multi-arm, multi-arm heterofunctional disubstituted, amino-polyglycolic, N-terminated polyethylene glycol-modified, and thiol-modified polyethylene glycol PEG pro...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2001
• Employees: 269
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688356

Financial Performance

In 2025, Jenkem Technology's revenue was 318.22 million, an increase of 40.13% compared to the previous year's 227.10 million. Earnings were 61.70 million, an increase of 106.78%.